Cargando…

HLA-G as a Tolerogenic Molecule in Transplantation and Pregnancy

HLA-G is a nonclassical HLA class I molecule. In allogeneic situations such as pregnancy or allograft transplantation, the expression of HLA-G has been related to a better acceptance of the fetus or the allograft. Thus, it seems that HLA-G is crucially involved in mechanisms shaping an allogeneic im...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rebmann, Vera, da Silva Nardi, Fabiola, Wagner, Bettina, Horn, Peter A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4131093/ https://www.ncbi.nlm.nih.gov/pubmed/25143957 http://dx.doi.org/10.1155/2014/297073

Ejemplares similares

The Potential of HLA-G-Bearing Extracellular Vesicles as a Future Element in HLA-G Immune Biology
por: Rebmann, Vera, et al.
Publicado: (2016)

Recombinant HLA-G as Tolerogenic Immunomodulant in Experimental Small Bowel Transplantation
por: von Websky, Martin W., et al.
Publicado: (2016)

Recipient HLA-G +3142 CC Genotype and Concentrations of Soluble HLA-G Impact on Occurrence of CMV Infection after Living-Donor Kidney Transplantation
por: Guberina, Hana, et al.
Publicado: (2017)

Effect of HLA-G5 Immune Checkpoint Molecule on the Expression of ILT-2, CD27, and CD38 in Splenic B cells
por: Rohn, Hana, et al.
Publicado: (2022)

Soluble HLA-G and HLA-G Bearing Extracellular Vesicles Affect ILT-2 Positive and ILT-2 Negative CD8 T Cells Complementary
por: Schwich, Esther, et al.
Publicado: (2020)

The Paradox of High Availability and Low Recognition of Soluble HLA-G by LILRB1 Receptor in Rheumatoid Arthritis Patients
por: Degani Veit, Tiago, et al.
Publicado: (2015)

Inhibition of iNKT Cells by the HLA-G-ILT2 Checkpoint and Poor Stimulation by HLA-G-Expressing Tolerogenic DC
por: Wu, Ching-Lien, et al.
Publicado: (2021)

Tolerogenic therapies in transplantation
por: Page, Eugenia K., et al.
Publicado: (2012)

HLA-G Expression on Blasts and Tolerogenic Cells in Patients Affected by Acute Myeloid Leukemia
por: Locafaro, Grazia, et al.
Publicado: (2014)

Vesicular-Bound HLA-G as a Predictive Marker for Disease Progression in Epithelial Ovarian Cancer
por: Schwich, Esther, et al.
Publicado: (2019)

HLA-G 3′ untranslated region variants +3187G/G, +3196G/G and +3035T define diametrical clinical status and disease outcome in epithelial ovarian cancer
por: Schwich, Esther, et al.
Publicado: (2019)

Costimulatory Molecules on Immunogenic Versus Tolerogenic Human Dendritic Cells
por: Hubo, Mario, et al.
Publicado: (2013)

Tolerogenic Function of Dimeric Forms of HLA-G Recombinant Proteins: A Comparative Study In Vivo
por: Favier, Benoit, et al.
Publicado: (2011)

Genetic Variants of the NKG2C/HLA-E Receptor–Ligand Axis Are Determinants of Progression-Free Survival and Therapy Outcome in Aggressive B-Cell Lymphoma
por: Wagner, Bettina, et al.
Publicado: (2020)

Tolerogenic Dendritic Cells on Transplantation: Immunotherapy Based on Second Signal Blockage
por: Silva, Priscila de Matos, et al.
Publicado: (2015)

The role of HLA-G in human pregnancy
por: Hunt, Joan S, et al.
Publicado: (2006)

HLA-G and Recurrent Pregnancy Loss
por: Barbaro, Greta, et al.
Publicado: (2023)

Cell therapy using tolerogenic dendritic cells in transplantation
por: Moreau, Aurélie, et al.
Publicado: (2012)

Elevated sHLA-G plasma levels post chemotherapy combined with ILT-2 rs10416697C allele status of the sHLA-G-related receptor predict poorest disease outcome in early triple-negative breast cancer patients
por: Hoffmann, Oliver, et al.
Publicado: (2023)

HLA-E expression constitutes a novel determinant for ALL disease monitoring following hematopoietic stem cell transplantation
por: Reusing, Sarah B., et al.
Publicado: (2021)

HLA-E Polymorphism Determines Susceptibility to BK Virus Nephropathy after Living-Donor Kidney Transplant
por: Rohn, Hana, et al.
Publicado: (2019)

Editorial: “The Role of Immune Checkpoint Molecules in Solid and Hematopoietic Stem Cell Transplantation”
por: Kordelas, Lambros, et al.
Publicado: (2021)

The Tolerogenic Function of Regulatory T Cells in Pregnancy and Cancer
por: Jørgensen, Nanna, et al.
Publicado: (2019)

Peripheral HLA-G/ILT-2 immune checkpoint axis in acute and convalescent COVID-19 patients
por: Rohn, Hana, et al.
Publicado: (2023)

Polymorphic Sites at the 3’ Untranslated Region of the HLA-G Gene Are Associated with Differential hla-g Soluble Levels in the Brazilian and French Population
por: Martelli-Palomino, Gustavo, et al.
Publicado: (2013)

Infection and HLA-G Molecules in Nasal Polyposis
por: Rizzo, Roberta, et al.
Publicado: (2014)

HLA-G Molecules in Autoimmune Diseases and Infections
por: Rizzo, Roberta, et al.
Publicado: (2014)

The Role of HLA-G Molecule and HLA-G Gene Polymorphisms in Tumors, Viral Hepatitis, and Parasitic Diseases
por: Dias, Fabrício C., et al.
Publicado: (2015)

Tolerogenic Role of Myeloid Suppressor Cells in Organ Transplantation
por: Ochando, Jordi, et al.
Publicado: (2019)

Tolerogenic Dendritic Cells: The Pearl of Immunotherapy in Organ Transplantation
por: Zhuang, Quan, et al.
Publicado: (2020)

The Donor Major Histocompatibility Complex Class I Chain-Related Molecule A Allele rs2596538 G Predicts Cytomegalovirus Viremia in Kidney Transplant Recipients
por: Rohn, Hana, et al.
Publicado: (2018)

Systematic Evaluation of HLA-G 3’Untranslated Region Variants in Locally Advanced, Non-Metastatic Breast Cancer Patients: UTR-1, 2 or UTR-4 are Predictors for Therapy and Disease Outcome
por: Rebmann, Vera, et al.
Publicado: (2022)

HLA-G and Other Immune Checkpoint Molecules as Targets for Novel Combined Immunotherapies
por: Morandi, Fabio, et al.
Publicado: (2022)

The Effects of Tamoxifen on Tolerogenic Cells in Cancer
por: Mohd Idris, Ros Akmal, et al.
Publicado: (2022)

Tolerogenic vaccines for the treatment of cardiovascular diseases
por: Vigario, Fernando Lozano, et al.
Publicado: (2020)

HLA molecules in transplantation, autoimmunity and infection control: A comic book adventure
por: Reits, Eric, et al.
Publicado: (2022)

Alternative approaches to myeloid suppressor cell therapy in transplantation: comparing regulatory macrophages to tolerogenic DCs and MDSCs
por: Riquelme, Paloma, et al.
Publicado: (2012)

Tolerogenic Dendritic Cell-Based Approaches in Autoimmunity
por: Passeri, Laura, et al.
Publicado: (2021)

Functional Ambivalence of Dendritic Cells: Tolerogenicity and Immunogenicity
por: Nam, Ji-Hee, et al.
Publicado: (2021)

The Activating NKG2C Receptor Is Significantly Reduced in NK Cells after Allogeneic Stem Cell Transplantation in Patients with Severe Graft-versus-Host Disease
por: Kordelas, Lambros, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_iqkd9sj7t4c49jj6ovb0hv1esb